Krepulat Frauke, Löhler Jürgen, Heinlein Christina, Hermannstädter Andrea, Tolstonog Genrich V, Deppert Wolfgang
Heinrich-Pette-Institut für Experimentelle Virologie und Immunologie an der Universität Hamburg, Martinistrasse 52, D-20251 Hamburg, Germany.
Oncogene. 2005 Jul 7;24(29):4645-59. doi: 10.1038/sj.onc.1208557.
We describe the construction and phenotypic characterization of 23 whey acidic protein (WAP)-mutp53 transgenic mouse lines. The mutp53-expressing lines showed a mosaic expression pattern for the transgenes, leading to a heterogeneous yet mouse line-specific expression pattern for mutp53 upon induction. Only few lines were obtained, in which the majority of the induced mammary epithelial cells expressed the mutp53 transgene, most of the transgenic lines did not express mutp53, or expressed the transgene in less than 2% of the induced mammary epithelial cells. Hormone requirements for mutp53 transgene expression from the WAP-promoter differed in high and low expressing lines, being low in high expressing lines, and even lower in multiparous mutp53 mice, where persistent expression of the transgene occurred. Repeated induction of mutp53 expression through repeated parturition resulted in the formation of expanding mutp53-expressing foci within the mammary alveolar epithelium. The data suggest that epigenetic mechanisms play a role in modulating the expression of the mutp53 transgene. To support this idea, we crossed a nonexpressing WAP-mutp53 line with a strongly SV40 T-antigen-expressing WAP-T mouse line. In the bitransgenic mice, T-antigen-induced chromatin remodeling led to re-expression of epigenetically silenced mutp53 transgene(s). In these mice, mutp53 expression was much more variable compared to SV40 T-antigen expression, and seemed to depend on the coexpression of SV40 T-antigen. Mutp53 expression in this system thus resembles the situation in many human tumors, where one can observe a heterogeneous expression of mutp53, despite a homogeneous distribution of the p53 mutation in the tumor cells.
我们描述了23种乳清酸性蛋白(WAP)-突变型p53转基因小鼠品系的构建及其表型特征。表达突变型p53的品系显示出转基因的镶嵌表达模式,诱导后导致突变型p53呈现异质性但品系特异性的表达模式。仅获得少数品系,其中大多数诱导的乳腺上皮细胞表达突变型p53转基因,大多数转基因品系不表达突变型p53,或在不到2%的诱导乳腺上皮细胞中表达转基因。来自WAP启动子的突变型p53转基因表达的激素需求在高表达和低表达品系中有所不同,在高表达品系中较低,在多胎突变型p53小鼠中甚至更低,其中转基因持续表达。通过重复分娩反复诱导突变型p53表达导致在乳腺腺泡上皮内形成不断扩大的表达突变型p53的病灶。数据表明表观遗传机制在调节突变型p53转基因的表达中起作用。为支持这一观点,我们将一个不表达的WAP-突变型p53品系与一个强烈表达SV40 T抗原的WAP-T小鼠品系杂交。在双转基因小鼠中,T抗原诱导的染色质重塑导致表观遗传沉默的突变型p53转基因重新表达。在这些小鼠中,与SV40 T抗原表达相比,突变型p53表达的变异性要大得多,并且似乎依赖于SV40 T抗原的共表达。因此,该系统中突变型p53的表达类似于许多人类肿瘤中的情况,在肿瘤细胞中尽管p53突变分布均匀,但仍可观察到突变型p53的异质性表达。